Reduction of heart rate variability after colorectal resections.
O Haase, C Langelotz, M Scharfenberg...
https://pubmed.ncbi.nlm.nih.gov/22249435/Actively Recruiting
Led by Institut du Cancer de Montpellier - Val d'Aurelle · Updated on 2026-01-16
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the use of a cardiac coherence breathing technique to reduce anxiety in patients diagnosed with peritoneal carcinomatosis from colon, stomach, ovary cancers, pseudomyxoma peritonei, or peritoneal mesothelioma. These patients often experience significant psychological distress before surgery due to the severity of their condition and treatment burden. The study aims to assess the feasibility and benefits of this non-drug intervention known for its calming effects, focusing on adherence to the program and its impact on anxiety, immune response, and quality of life. Participants will be randomly assigned to either a cardiac coherence program or standard care. The cardiac coherence group will begin with an initiation session 11 days before surgery to learn breathing exercises using an app and audio guidance. They will then perform three 5-minute breathing sessions daily before meals for the 11 days leading up to surgery and continue the program for 90 days post-surgery. The standard care group will receive usual treatment without the cardiac coherence intervention. During the study, participants will be monitored through anxiety scales, psychological distress assessments, heart rate variability, quality of life questionnaires, pain evaluations, and immune markers such as salivary immunoglobulin A. Researchers will track adherence rates, number and duration of breathing sessions, hospitalization days after surgery, and patient satisfaction over about one year. Safety and psychological effects will be closely followed, with data collected at intervals up to 90 days and longer term through study completion.
CONDITIONS
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
J
Jean-Pierre BLEUSE, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Institut du Cancer de Montpellier - Val d'Aurelle
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during surgical consultation
Duration - 11 days
Participants in the cardiac coherence group receive an initiation session and practice breathing exercises 3 times daily for 11 days before surgery to prepare for the intervention.
1 initiation session and daily practice at home
Duration - 1 day
Participants undergo cytoreductive surgery for peritoneal carcinomatosis.
Hospitalization at the Institute of Cancer of Montpellier the day before surgery
Duration - 90 days
Participants continue the cardiac coherence breathing exercises during the 90 days following surgery to reduce anxiety and support recovery.
Daily practice at home
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
O Haase, C Langelotz, M Scharfenberg...
https://pubmed.ncbi.nlm.nih.gov/22249435/David A Chambers, Wynne E Norton
https://pubmed.ncbi.nlm.nih.gov/27371105/L E Scott, G A Clum, J B Peoples
https://pubmed.ncbi.nlm.nih.gov/6856324/Fatih Kayhan, Erdinc Cıcek, Faruk Uguz...
https://pubmed.ncbi.nlm.nih.gov/23602607/Saho Wada, Hironobu Inoguchi, Ryoichi Sadahiro...
https://pubmed.ncbi.nlm.nih.gov/30128769/Carissa A Low, Dana H Bovbjerg, Steven Ahrendt...
https://pubmed.ncbi.nlm.nih.gov/26903574/N K Aaronson, S Ahmedzai, B Bergman...
https://pubmed.ncbi.nlm.nih.gov/8433390/Justin P Fox, Errol J Philip, Cary P Gross...
https://pubmed.ncbi.nlm.nih.gov/23521554/M Pinquart, P R Duberstein
https://pubmed.ncbi.nlm.nih.gov/20085667/Giulia Cossu, Luca Saba, Luigi Minerba...
https://pubmed.ncbi.nlm.nih.gov/29643929/Institut du Cancer de Montpellier - Val d'Aurelle
Lead Sponsor